Position in BHC
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$708,361
+$368,805 QoQ
Shares Held
131,178
+168.5% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026WINTON GROUP Ltd holds $21,925,909 across 23 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
159,508 | $5,530,142 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
55,058 | $4,557,701 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
255,600 | $2,556,000 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
144,816 | $2,506,764 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
2,292 | $1,241,874 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
22,143 | $908,527 | |
| 7 | PRGO |
PERRIGO Co plc
|
75,700 | $786,523 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
14,800 | $535,760 |
All Filings in BHC
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $708,361 | 131,178 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $339,556 | 48,857 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $309,509 | 47,986 | Shares | Sole | 2025-11-13 | |
| 2022-12-31 | $640,252 | 101,951 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $264,568 | 31,647 | Shares | Sole | 2022-08-10 | |
| No filing history on record for this holder in this stock. | ||||||